MYRIAD GENETICS INC — Director's Dealing 2024

Mar 28, 2024

SEC Form 4/A — Form 4/A

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2024-03-14

Reporting Person: Leffler Scott J. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-14	Common Stock	A	46905	—	Acquired	164675	Direct

Footnotes

F1: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

F2: This amendment corrects the number of restricted stock units granted to the reporting person on March 14, 2024, which was incorrectly under reported by 810 restricted stock units on the original filing as a result of a clerical error.